SCOPUS 정보 검색 플랫폼

Gastroenterology

Volumn 122, Issue 2, 2002, Pages 565-567

HMG-CoA reductase inhibitors for the treatment of pancreatic cancer

(1) Schmid, Roland M a

a UNIVERSITY OF ULM (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036158682 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/gast.2002.31473 Document Type: Article

Times cited : (4)

References (12)

1
- 0000990627
- Molecular biology of cancer: Invasion and metastases
- DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia, Lippincott Williams & Wilkins
- (2001) Cancer: Principles and practice of oncology. 6th ed. , pp. 123-126
- Stetler-Stevenson, W.G.¹ Kleiner Jr., D.E.²

2
- 0036158675
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion in vitro and metastasis in vivo
- (2002) Gastroenterology , vol.122 , pp. 308-317
- Kusama, T.¹ Mukai, M.² Iwasaki, T.³ Tatsuta, M.⁴ Matsumoto, Y.⁵ Akedo, H.⁶ Inoue, M.⁷ Nakamura, H.⁸

3
- 0035874879
- Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors
- (2001) Cancer Res , vol.61 , pp. 4885-4891
- Kusama, T.¹ Mukai, M.² Iwasaki, T.³ Tatsuta, M.⁴ Matsumoto, Y.⁵ Akedo, H.⁶ Nakamura, H.⁷

4
- 0034908034
- Cervastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: An in vitro study
- (2001) Carcinogenesis , vol.22 , pp. 1139-1148
- Denoyelle, C.¹ Vasse, M.² Körner, M.³ Mishal, Z.⁴ Ganne, F.⁵ Vannier, J.-P.⁶ Soria, J.⁷ Soria, C.⁸

5
- 0034613286
- RhoA prenylation is required for promotion of cell growth and transformation, cytoskeleton organization, but not for induction of SRE transcription
- (2000) J Biol Chem , vol.275 , pp. 31005-31008
- Allal, C.¹ Favre, G.² Couderc, B.³ Salicio, S.⁴ Sixou, S.⁵ Hamilton, A.D.⁶ Sebti, S.M.⁷ Lajoie-Mazenc, I.⁸ Pradines, A.⁹

6
- 0028535302
- Selective inhibition of primary acute myeloid leukemia cell growth by simvastatin
- (1994) Leukemia (Basingstoke) , vol.8 , pp. 2023-2029
- Newman, A.¹ Clutterbuck, R.D.² Powels, R.L.³ Catovsky, D.⁴ Millar, J.L.⁵

7
- 0031747545
- Lovastatin induces apoptosis in malignant mesothelioma cells
- (1998) Am J Respir Crit Care Med , vol.157 , pp. 1616-1622
- Rubins, J.B.¹ Greatens, T.² Kratzke, R.A.³ Tan, A.T.⁴ Polunovsky, V.A.⁵ Bittermam, P.⁶

8
- 0032933952
- Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro
- (1999) J Neurooncol , vol.42 , pp. 1-11
- Macaulay, R.J.¹ Wang, W.² Dimitroulakos, J.³ Becker, L.E.⁴ Yeger, H.⁵

9
- 0032892429
- Lovastsatin-induced proliferation inhibition and apoptosis in C6 glial cells
- (1999) J Pharmacol Exp Ther , vol.289 , pp. 572-579
- Choi, J.W.¹ Jung, S.E.²

10
- 0030993888
- A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukemic and normal bone marrow progenitors
- (1997) Leuk Lymphoma , vol.24 , pp. 533-537
- Newman, A.¹ Clutterbuck, R.D.² Powels, R.L.³ Catovsky, D.⁴ Millar, J.L.⁵

11
- 0035957682
- Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: Contribution to its anti-angiogenic effect
- (2001) FEBS Lett , vol.495 , pp. 159-166
- Vincent, L.¹ Chen, W.² Hong, L.³ Mirshahi, F.⁴ Mishal, Z.⁵ Mirshahi-Khorassani, T.⁶ Vannier, J.-P.⁷ Soria, J.⁸ Soria, C.⁹

12
- 0034726387
- 3-Hydroxy-3-methylglutaaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
- (2000) Arch Intern Med , vol.160 , pp. 2363-2368
- Blais, L.¹ Desgagne, A.² LeLorier, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.